Differential cell autonomous responses determine the outcome of coxsackievirus infections in murine pancreatic α and β cells

  1. Laura Marroqui Esclapez
  2. Miguel Lopes
  3. Reinaldo S dos Santos
  4. Fabio A Grieco
  5. Merja Roivainen
  6. Sarah J Richardson
  7. Noel G Morgan
  8. Anne Op de beeck
  9. Decio L Eizirik  Is a corresponding author
  1. Universite Libre de Bruxelles, Belgium
  2. National Institute for Health and Welfare, Finland
  3. University of Exeter Medical School, United Kingdom

Abstract

Type 1 diabetes (T1D) is an autoimmune disease caused by loss of pancreatic β cells via apoptosis while neighbouring α cells are preserved. Viral infections by Coxsackieviruses (CVB) may contribute to trigger autoimmunity in T1D. Cellular permissiveness to viral infection is modulated by innate antiviral responses, which vary among different cell types. We presently describe that global gene expression is similar in cytokine-treated and virus-infected human islet cells, with up-regulation of gene networks involved in cell autonomous immune responses. Comparison between the responses of rat pancreatic α and β cells to infection by CVB5 and 4 indicate that α cells trigger a more efficient antiviral response than β cells, including higher basal and induced expression of STAT1-regulated genes, and are thus better able to clear viral infections than β cells. These differences may explain why pancreatic β cells, but not α cells, are targeted by an autoimmune response during T1D.

Article and author information

Author details

  1. Laura Marroqui Esclapez

    ULB Center for Diabetes Research, Medical Faculty, Universite Libre de Bruxelles, Brussels, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  2. Miguel Lopes

    ULB Center for Diabetes Research, Medical Faculty, Universite Libre de Bruxelles, Brussels, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  3. Reinaldo S dos Santos

    ULB Center for Diabetes Research, Medical Faculty, Universite Libre de Bruxelles, Brussels, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  4. Fabio A Grieco

    ULB Center for Diabetes Research, Medical Faculty, Universite Libre de Bruxelles, Brussels, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  5. Merja Roivainen

    National Institute for Health and Welfare, Helsinki, Finland
    Competing interests
    The authors declare that no competing interests exist.
  6. Sarah J Richardson

    Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Noel G Morgan

    Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Anne Op de beeck

    ULB Center for Diabetes Research, Medical Faculty, Universite Libre de Bruxelles, Brussels, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  9. Decio L Eizirik

    ULB Center for Diabetes Research, Medical Faculty, Universite Libre de Bruxelles, Brussels, Belgium
    For correspondence
    deizirik@ulb.ac.be
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Mark McCarthy, Oxford University, United Kingdom

Ethics

Animal experimentation: Male Wistar rats (Charles River Laboratories, L'Arbresle Cedex, France) were housed and used according to the guidelines of the Belgian Regulations for Animal Care, with the approval by the local Ethical Committee (protocol number 465N; period of validity 07/2013-07/2017).

Human subjects: Human islets were isolated from 2 non-diabetic organ donors with approval from the local Ethical Committee in Pisa, Italy. Organ and tissue donation in Italy is regulated by the art. 23 of the national law n. 91, issued on April 1st, 1999; in Tuscany the regional transplant organization (OTT, Organizzazione Toscana Trapianti) allows that organs not suitable for clinical transplantation are used for research purposes provided informed consent has been signed by the responsible relative. Prof. Marchetti's group has access to donated pancreases for the preparation and study of isolated islets on the basis of approval by their local ethics committee, renewed in 2013.

Version history

  1. Received: February 14, 2015
  2. Accepted: June 8, 2015
  3. Accepted Manuscript published: June 10, 2015 (version 1)
  4. Version of Record published: June 25, 2015 (version 2)

Copyright

© 2015, Marroqui Esclapez et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,942
    views
  • 355
    downloads
  • 51
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Laura Marroqui Esclapez
  2. Miguel Lopes
  3. Reinaldo S dos Santos
  4. Fabio A Grieco
  5. Merja Roivainen
  6. Sarah J Richardson
  7. Noel G Morgan
  8. Anne Op de beeck
  9. Decio L Eizirik
(2015)
Differential cell autonomous responses determine the outcome of coxsackievirus infections in murine pancreatic α and β cells
eLife 4:e06990.
https://doi.org/10.7554/eLife.06990

Share this article

https://doi.org/10.7554/eLife.06990

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Christopher TA Lewis, Elise G Melhedegaard ... Julien Ochala
    Research Article

    Hibernation is a period of metabolic suppression utilized by many small and large mammal species to survive during winter periods. As the underlying cellular and molecular mechanisms remain incompletely understood, our study aimed to determine whether skeletal muscle myosin and its metabolic efficiency undergo alterations during hibernation to optimize energy utilization. We isolated muscle fibers from small hibernators, Ictidomys tridecemlineatus and Eliomys quercinus and larger hibernators, Ursus arctos and Ursus americanus. We then conducted loaded Mant-ATP chase experiments alongside X-ray diffraction to measure resting myosin dynamics and its ATP demand. In parallel, we performed multiple proteomics analyses. Our results showed a preservation of myosin structure in U. arctos and U. americanus during hibernation, whilst in I. tridecemlineatus and E. quercinus, changes in myosin metabolic states during torpor unexpectedly led to higher levels in energy expenditure of type II, fast-twitch muscle fibers at ambient lab temperatures (20 °C). Upon repeating loaded Mant-ATP chase experiments at 8 °C (near the body temperature of torpid animals), we found that myosin ATP consumption in type II muscle fibers was reduced by 77–107% during torpor compared to active periods. Additionally, we observed Myh2 hyper-phosphorylation during torpor in I. tridecemilineatus, which was predicted to stabilize the myosin molecule. This may act as a potential molecular mechanism mitigating myosin-associated increases in skeletal muscle energy expenditure during periods of torpor in response to cold exposure. Altogether, we demonstrate that resting myosin is altered in hibernating mammals, contributing to significant changes to the ATP consumption of skeletal muscle. Additionally, we observe that it is further altered in response to cold exposure and highlight myosin as a potentially contributor to skeletal muscle non-shivering thermogenesis.

    1. Cell Biology
    Jun Yang, Shitian Zou ... Xiaochun Bai
    Research Article

    Quiescence (G0) maintenance and exit are crucial for tissue homeostasis and regeneration in mammals. Here, we show that methyl-CpG binding protein 2 (Mecp2) expression is cell cycle-dependent and negatively regulates quiescence exit in cultured cells and in an injury-induced liver regeneration mouse model. Specifically, acute reduction of Mecp2 is required for efficient quiescence exit as deletion of Mecp2 accelerates, while overexpression of Mecp2 delays quiescence exit, and forced expression of Mecp2 after Mecp2 conditional knockout rescues cell cycle reentry. The E3 ligase Nedd4 mediates the ubiquitination and degradation of Mecp2, and thus facilitates quiescence exit. A genome-wide study uncovered the dual role of Mecp2 in preventing quiescence exit by transcriptionally activating metabolic genes while repressing proliferation-associated genes. Particularly disruption of two nuclear receptors, Rara or Nr1h3, accelerates quiescence exit, mimicking the Mecp2 depletion phenotype. Our studies unravel a previously unrecognized role for Mecp2 as an essential regulator of quiescence exit and tissue regeneration.